Search
Search Results
-
Is an oropharyngeal HPV infection more frequently detectable in women with a genital HPV infection?
PurposeIf not eliminated by the immune system and persisting over years, oropharyngeal high-risk HPV infection can lead to cancer development in the...
-
Development and validation of HPV-associated and HPV-independent penile squamous cell carcinoma prognostic nomogram
ObjectiveThe aim of this study was to introduce HPV-associated and HPV-independent histologic classifications to analyze prognostic factors and...
-
Disparities in HPV and the HPV Vaccine Knowledge Among Non-Hispanic Black Adults in the US - HINTS 2017–2020
Disparities persists in HPV awareness and vaccination among different racial and ethnic groups. We assessed disparities in awareness of HPV and the...
-
HPV and HPV Vaccine Awareness Among African Americans in the Black Belt Region of Alabama
This study aims to examine the factors associated with the level of HPV infection and HPV vaccine awareness among rural African Americans living in...
-
A Rapid, Sensitive and Type-Specific Detection of High-Risk HPV-16 and HPV-18
Human papillomavirus (HPV) infection, particularly infection with HPVs 16 and 18, is a major cause of cervical cancer. The current high-risk HPV...
-
Older women’s perceptions of HPV self-sampling and HPV-sampling performed by a midwife – a phenomenographic study
BackgroundCervical cancer is a global disease and it is well established that cervical cancer is caused by human papillomavirus (HPV). In Sweden...
-
Detection of antibody subclasses IgA, IgM and IgG against HPV L1 in HPV-positive oropharyngeal squamous cell carcinoma patients: a pilot study
PurposeDespite prognostic superiority of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC), up to 25% of patients will suffer from...
-
Zervixkarzinomprävention durch HPV-Impfung und Früherkennung
Human papillomaviruses (HPV) are very widespread, so that most women and men become infected during their lifetime. In Germany approximately 7850...
-
Prevention and control of HPV and HPV-related cancers in France: the evolving landscape and the way forward – a meeting report
Misinformation regarding HPV vaccine safety and benefits has resulted in low coverage within the eligible French population. HPV vaccination is safe...
-
EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells
Our previous laboratory findings suggested the beneficial effects of epigallocatechin gallate (EGCG) against cervical cancer (CC) cells survival. The...
-
Attitudes toward an HPV vaccine for condyloma acuminata and willingness to undergo vaccination among STD clinic attendees in China: Focus on STI prevention with HPV vaccine
BackgroundCondyloma acuminata (CA) is a common, and recurrent sexually transmitted disease (STD) that greatly contributes to direct health care costs...
-
Impact of HPV vaccination on HPV infection and cervical related disease burden in real-world settings (HPV-RWS): protocol of a prospective cohort
BackgroundCervical cancer is one of the most common cancers in women and could be prevented by human papilloma virus (HPV) vaccination. Cervarix ,...
-
Knowledge and perceptions regarding Human Papillomavirus (HPV) and willingness to receive HPV vaccination among university students in a north-eastern city in Turkey
BackgroundFor a HPV vaccination program to be successful, it is important that the target population has sufficient knowledge about HPV and HPV...
-
Human Papillomavirus Vaccine Acceptance (HPV-VA) and Vaccine Uptake (HPV-VU): assessing the impact of theory, culture, and trusted sources of information in a Hispanic community
BackgroundHuman papillomavirus (HPV) is the most common sexually transmitted infection and is associated with many types of cancers that...
-
HPV-Impfung: neue Daten und Indikation in der Sekundärprävention
Human papillomaviruses (HPV) cause numerous benign and malignant lesions/tumors of skin and mucosa, including genital warts, recurrent laryngeal...
-
Incorporating HPV 33 and cytology into HPV 16/18 screening may be feasible. A cross-sectional study
PurposeThe distribution of human papillomavirus (HPV) varies geographically, and each country is making its screening and vaccination program. This...
-
Chlamydia trachomatis enhances HPV persistence through immune modulation
Chlamydia trachomatis (CT) is the most common sexually transmitted infections globally, and CT infection can enhance HPV persistence. Epidemiological...
-
Challenges with the use of Xpert HPV as a screening tool for oral HPV among people living with HIV (PLHIV): experiences from Pune, India
BackgroundPeople living with HIV (PLHIV) are at higher risk for human papillomavirus (HPV)-related oropharyngeal cancers compared to the general...
-
“Easy women get it”: pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program
BackgroundCervical cancer is preventable with vaccination and early detection and treatment programs. However, for these programs to work as...
-
A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
IntroductionThe following study aimed to answer the question if HPV-HNCUP and HPV-OPSCC are the same disease. Propensity score matching (PSM) was...
